Drug side effects
dipyridamole Side Effects
The reactions most often reported to the FDA for dipyridamole (also sold as Persantine), with demographics, serious outcomes, and reporting trends.
Data updated 2026-05-15
- 3,682
- FAERS reports
Data from the FDA Adverse Event Reporting System (FAERS), 2002 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.
The most commonly reported side effects of dipyridamole come from 3,682 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.
This page analyzes 3,682 reports to the FDA Adverse Event Reporting System (FAERS) for dipyridamole (Persantine): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.
Total Reports
3,682
Reports Mentioning Death
459
12.5% of reports — not proof the medicine caused the death
Hospitalizations
1,894
51.4% of reports
Top Indication
Product Used For Unknown Indication
Most Reported Adverse Reactions
Who Reports Side Effects
Gender Distribution
Age Distribution
Reporting Trend by Year
Reactions in Death Reports
Top reactions reported in 459 reports where death was an outcome. These are voluntarily reported and do not establish causation.
| Reaction | Reports |
|---|---|
| DEATH | 73 |
| PNEUMONIA | 37 |
| CEREBRAL HAEMORRHAGE | 29 |
| CEREBROVASCULAR ACCIDENT | 29 |
| RENAL FAILURE | 27 |
| MULTI-ORGAN FAILURE | 25 |
| SEPSIS | 25 |
| EMBOLISM | 22 |
| DIARRHOEA | 19 |
| NEUROLOGICAL SYMPTOM | 19 |
| HAEMORRHAGE INTRACRANIAL | 18 |
| HYPOTENSION | 18 |
| MYOCARDIAL INFARCTION | 18 |
| NEUTROPENIC SEPSIS | 18 |
| DYSPNOEA | 17 |
| GASTROINTESTINAL HAEMORRHAGE | 17 |
| HAEMORRHAGE | 17 |
| NAUSEA | 17 |
| ANAEMIA | 16 |
Reactions in Hospitalization Reports
Top reactions in 1,894 reports where hospitalization was an outcome.
| Reaction | Reports |
|---|---|
| FALL | 525 |
| HYPOTENSION | 484 |
| COGNITIVE DISORDER | 479 |
| PAIN | 462 |
| DEPRESSED LEVEL OF CONSCIOUSNESS | 459 |
| ORTHOSTATIC HYPOTENSION | 456 |
| CONSTIPATION | 455 |
| BALANCE DISORDER | 449 |
| SEDATION COMPLICATION | 446 |
| BLOOD CALCIUM DECREASED | 435 |
| CREATININE RENAL CLEARANCE DECREASED | 435 |
| MOBILITY DECREASED | 430 |
| SEDATION | 425 |
| TOXICITY TO VARIOUS AGENTS | 366 |
| DYSPNOEA | 170 |
| DRUG INTERACTION | 133 |
| VOMITING | 82 |
| CEREBROVASCULAR ACCIDENT | 77 |
Nearby, Related Medications
What the FAERS Data Reveals About dipyridamole Side Effects
The FDA Adverse Event Reporting System (FAERS) contains 3,682 voluntary reports linked to dipyridamole and its brand equivalents (Persantine), spanning 2002 through 2025. Of those, 459 (12.5%) listed death as an outcome and 1,894 (51.4%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.
Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 53% were female and 46% male; age distribution skews toward 75+, with 1,235 reports in that bracket. The single most reported reaction is fall with 545 submissions, followed by hypotension and pain.
How to read these numbers
FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.
Drugs With a Similar FAERS Report Volume
Other medications with a total FDA adverse-event report count closest to dipyridamole's 3,682.
Read our methodology - how this data is sourced, computed, and verified.